Frank S Czerwiec

Title: Frank S. Czerwiec: Innovator in Therapeutic Risk Management

Introduction

Frank S. Czerwiec is a notable inventor based in Potomac, MD (US). He has made significant contributions to the field of therapeutic risk management, holding two patents that showcase his innovative approach to healthcare technology.

Latest Patents

Czerwiec's latest patents focus on a device-based risk management system (RMS) for therapeutic agents. The RMS device includes a comprehensive database and processor designed to manage patient enrollment in therapeutic programs. The system features a prescriber module that receives requests to enroll patients, specifying indications and confirming diagnostic tests. Additionally, the RMS processor generates patient profiles and stores them in the database. It also includes an authorization module that produces an authorization code to determine if a patient is eligible to receive the therapeutic agent. This code is then transmitted to pharmacies or prescribers, streamlining the process of patient care.

Career Highlights

Frank S. Czerwiec is currently associated with Otsuka Pharmaceutical Company, Limited, where he continues to develop innovative solutions in the pharmaceutical industry. His work emphasizes the importance of risk management in therapeutic applications, contributing to improved patient outcomes.

Collaborations

Czerwiec has collaborated with notable colleagues, including Amy Freedman and Keith Friend, enhancing the development of his innovative projects. Their combined expertise fosters a collaborative environment that drives advancements in therapeutic risk management.

Conclusion

Frank S. Czerwiec is a distinguished inventor whose work in therapeutic risk management is paving the way for improved healthcare solutions. His patents reflect a commitment to innovation and patient safety in the pharmaceutical industry.